ActX Named Greenway Online Marketplace Partner of the Month for Offering Integrated Genomic Decision Support
SEATTLE, Sept. 30, 2015 /PRNewswire/ -- ActX has been named Greenway Health's Partner of the Month for September 2015. ActX provides real-time genomic decision support to users of Greenway's Prime Suite integrated electronic health record (EHR) and practice management solution.
ActX ushers in a new era of precision medicine, enabling Greenway Health physicians to provide better patient care based on genetics. Based on affordable patient DNA testing, ActX checks each prescription for possible adverse reactions as well as efficacy issues using the patient's own genetic code. The ActX application alerts the physician about any serious, actionable medical risks, as well as risk factors and patients' carrier status. The ActX-Greenway integrated solution delivers actionable, evidence-based information physicians need, in a way they can trust.
"We are extremely excited to be named Partner of the Month for our genomic decision support services," says Dr. Andrew Ury, ActX CEO. "We're proud to offer precision medicine capabilities to Greenway Health users."
"Greenway Health is committed to enabling clinicians to deliver exceptional care," said Greg Shilling, vice president of business and corporate development. "The innovative ActX-Greenway integration allows Greenway physicians to easily incorporate decisions based on their patients' genomics into their daily workflow, improving patient care, and allowing for precision medicine to truly become a reality."
About ActX:
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient's genetic information to guide therapy. Integrated into a physician's normal software tools (the electronic medical record) and workflow, ActX analyzes the patient's genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks, risk factors and carrier status. For more information about ActX and taking the next step towards precision medicine, visit us at www.actx.com, contact us at [email protected] or call 888-998-2289.
Contact Information:
Susan Patten
Marketing Communications
ActX, Inc.
Email
888-998-2289
SOURCE ActX, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article